Asset Allocation

As of January 31, 2026.
Type % Net
Cash 1.37%
Stock 57.74%
Bond 40.36%
Convertible 0.00%
Preferred 0.00%
Other 0.52%
View Asset Allocation
Start Trial

Market Capitalization

As of January 31, 2026
Large 73.04%
Mid 18.26%
Small 8.70%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.14%    % Emerging Markets: 1.34%    % Unidentified Markets: 0.52%

Americas 59.74%
59.74%
Canada 39.50%
United States 20.24%
0.00%
As of January 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 25.24%
United Kingdom 7.35%
17.89%
Denmark 2.42%
Finland 5.17%
France 1.80%
Germany 0.90%
Ireland 1.73%
Switzerland 3.47%
0.00%
0.00%
Greater Asia 14.50%
Japan 8.89%
0.00%
4.55%
Hong Kong 3.12%
Singapore 1.44%
1.06%
China 1.06%
Unidentified Region 0.52%

Bond Credit Quality Exposure

AAA 34.19%
AA 19.44%
A 17.75%
BBB 21.58%
BB 2.41%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 4.64%
Short Term 0.00%
As of January 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
34.85%
Materials
10.29%
Consumer Discretionary
9.06%
Financials
15.50%
Real Estate
0.00%
Sensitive
34.67%
Communication Services
3.50%
Energy
3.58%
Industrials
17.90%
Information Technology
9.69%
Defensive
9.62%
Consumer Staples
1.70%
Health Care
7.92%
Utilities
0.00%
Not Classified
20.87%
Non Classified Equity
0.00%
Not Classified - Non Equity
20.87%
As of January 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of January 31, 2026
Type % Net
Government 32.98%
Corporate 35.41%
Securitized 0.00%
Municipal 26.72%
Other 4.89%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.14%
Less than 1 Year
0.14%
Intermediate
71.35%
1 to 3 Years
15.79%
3 to 5 Years
15.08%
5 to 10 Years
40.48%
Long Term
27.59%
10 to 20 Years
3.34%
20 to 30 Years
18.20%
Over 30 Years
6.05%
Other
0.92%
As of January 31, 2026
View Bond Maturity Exposure
Start Trial